TCL Archive NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08. September 21, 2007
TCL Archive Officials: Poisoning Unrelated to MD Anderson; Critics Allege Dysfunction in Handling of Affair September 19, 2014
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress June 25, 1976
